Coronary artery calcium screening in persons with metabolic syndrome and diabetes: implications for prevention
David M Tehrani1, Shaista Malik, Nathan D Wong
1Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, Irvine, CA 92697, USA.
Insights
Coronary artery calcium (CAC) screening effectively identifies subclinical coronary heart disease (CHD) in individuals with diabetes and metabolic syndrome. CAC scoring helps stratify risk, guiding more intensive therapies for high-risk patients.
Area of Science:
- Cardiology
- Preventive Medicine
- Metabolic Disorders
Background:
- Diabetes and metabolic syndrome are significant risk factors for coronary heart disease (CHD).
- Traditional risk assessment often fails to identify many patients experiencing CHD events.
- Early detection of subclinical CHD is crucial for identifying high-risk individuals.
Purpose of the Study:
- To review the role and benefits of coronary artery calcium (CAC) screening.
- To focus on the application of CAC screening in individuals with metabolic syndrome and diabetes mellitus.
- To evaluate CAC screening for assessing CHD risk in these specific populations.
Main Methods:
- Review of existing studies on CAC screening.
- Analysis of evidence regarding CAC extent and CHD risk in patients with and without metabolic syndrome and diabetes mellitus.
- Examination of updated guidelines for CAC screening in diabetes mellitus.
Main Results:
- The presence and extent of CAC are generally greater in individuals with diabetes and metabolic syndrome compared to those without.
- CHD risk significantly varies based on CAC extent in both individuals with and without these conditions.
- CAC screening aids in categorizing patients with intermediate and high CHD risk.
Conclusions:
- CAC screening offers added utility for CHD risk assessment, particularly in patients with metabolic syndrome and diabetes mellitus.
- CAC scoring helps stratify patients who may benefit from more intensive therapeutic interventions.
- Guidelines now support CAC screening for diabetes mellitus patients to refine risk stratification.
Abstract:
Abstract Diabetes and metabolic syndrome are major risk factors for coronary heart disease (CHD). Many patients suffering CHD events are not adequately identified by traditional risk assessment, suggesting the need for early detection of subclinical CHD to identify those at highest risk. Coronary artery calcium (CAC) screening has added utility in categorizing patients with intermediate and high risk of CHD events, and a growing body of evidence suggests its use for CHD risk assessment in persons with metabolic syndrome and diabetes mellitus. These studies demonstrate the presence and extent of CAC to be greater in those with these conditions, compared to those without, and that CHD risk varies greatly according to the extent of CAC both in persons with and without metabolic syndrome and diabetes mellitus. More recently, guidelines regarding the use of CAC screening have been extended to those with diabetes mellitus, helping to further stratify those patients that may benefit from more intensive therapy. This review evaluates the role and possible benefits of CAC screening, with a focus on those with metabolic syndrome and diabetes mellitus for evaluating the risk for CHD.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Imaging Studies for Cardiovascular System V: CT


